Search

Enter keywords, a title or a report id number below.

Order by Fax Ask a Question Printer Friendly PDF Brochure

Electronic (PDF) (Pre-Publication)

Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the title.

This product is pre-publication and is due to be released in June 2013. Order now at this special pre-publication price.

EURO€ 3,766.00USD$ 4,900.00GBP£ 3,169.00AUD$ 4,793.00JPY¥ 483,792.00SEK 32 173,00CHF 4'618.00CAD$ 4,993.00
Site License (Pre-Publication)

Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access the title.

This product is pre-publication and is due to be released in June 2013. Order now at this special pre-publication price.

EURO€ 5,650.00USD$ 7,350.00GBP£ 4,753.00AUD$ 7,189.00JPY¥ 725,687.00SEK 48 259,00CHF 6'928.00CAD$ 7,489.00
Enterprisewide (Pre-Publication)

Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access the title.

This product is pre-publication and is due to be released in June 2013. Order now at this special pre-publication price.

EURO€ 7,533.00USD$ 9,800.00GBP£ 6,338.00AUD$ 9,585.00JPY¥ 967,583.00SEK 64 345,00CHF 9'237.00CAD$ 9,986.00

Live Chat Live Help Software for Website

2012 CRO Quality Benchmarking - Phase I Service Providers

Industry Standard Research (ISR), June 2013, Pages: 165

This report, like our other CRO Benchmarking reports, is intended to provide the pharmaceutical and biotech industry and their service providers with third-party, objective data to better evaluate, select, and improve clinical outsourcing. This report focuses on providers of Phase I clinical pharmacology services.

WHAT YOU'LL LEARN

For Sponsors: Make more informed CRO selection decisions by understanding which Phase I CROs are the best fit for your individual organization’s needs

For Phase I Units:

- Improve clinical pharmacology service quality and create loyal customers
- Develop more effective RFP responses and increase new business wins
- Better position your Phase I unit to the competition
- Develop marketing messages that will resonate with your buyers

ATTRIBUTES EVALUATED

Each respondent was asked to rank the companies they have used in the past 18 months, across the following service quality attributes:

- Quality of the Phase I unit’s lead investigator
- Quality of clinic staff
- Technical expertise
- Ability to quickly recruit volunteers or patients
- Meeting schedules and timelines
- Breadth of services
- Range of tests, specialized equipment
- Low cost
- Overall value

MAJOR SECTIONS

Phase I Outsourcing Behaviors, Attitudes, Beliefs, and Intentions

Phase I Service Provider Selection Drivers

Phase I Service Provider Performance

Study Data

Companies Included:

- Chiltern
- INC Research
- Mepace
- Premier Research
- Rho
- SGS Life Sciences
- Siro Clinpharm
- US Oncology

Companies with Full Profiles:

- Bioclinica
- Cetero
- Charles River
- Covance
- DCRI - Duke
- ICON
- PAREXEL
- PharmaNet/i3
- PPD
- PRA
- Quintiles

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

* This product is pre-publication and is due to be released in June 2013. Order now at this special pre-publication price.

Customers who bought this item also bought

Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network

Viewing report

• ORDER BY FAX

• RECENTLY VIEWED

• REGISTER

• SELECT SITE CURRENCY

2012 CRO Quality Benchmarking - Phase I Service Providers

Industry Standard Research (ISR), June 2013, Pages: 165

Product Samples

Customers who bought this item also bought

For enquiries please call us on: